Published in Diabetologia on May 03, 2007
Rapamycin affects early fracture healing in mice. Br J Pharmacol (2008) 0.92
Tacrolimus inhibits the revascularization of isolated pancreatic islets. PLoS One (2013) 0.87
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes (2013) 0.85
Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cells. Acta Biomater (2012) 0.83
Endothelial progenitor cell cotransplantation enhances islet engraftment by rapid revascularization. Diabetes (2012) 0.83
Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells. J Investig Med (2008) 0.82
Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization. Drug Deliv Transl Res (2015) 0.82
In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation. PLoS One (2016) 0.75
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med (2002) 7.06
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol (1991) 5.61
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA (2005) 4.48
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature (2002) 4.10
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem (1998) 3.78
An improved method for isolation of mouse pancreatic islets. Transplantation (1985) 3.52
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res (2002) 3.19
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A (2001) 3.11
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res (2004) 3.03
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. Diabetes (2006) 2.53
Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol (2003) 2.00
Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes (2004) 1.85
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol (1995) 1.59
Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes (1998) 1.38
Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation (2005) 1.36
Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun (2003) 1.33
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol (2004) 1.33
Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology (1997) 1.30
Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes (1989) 1.27
Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes (2003) 1.25
The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit (2005) 1.14
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev (1996) 1.10
Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo. J Endocrinol (2005) 1.08
The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia (2006) 1.07
Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation (2006) 1.05
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int (2005) 1.04
Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol (2002) 1.03
Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J Clin Endocrinol Metab (1995) 1.01
Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation (2001) 1.00
Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation. Am J Transplant (2006) 0.97
Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes (2005) 0.97
Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharm Res (2006) 0.97
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation (2002) 0.96
Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest (2001) 0.94
An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery. Microcirculation (2004) 0.94
Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation (1997) 0.91
Induction of angiogenesis in omentum with vascular endothelial growth factor: influence on the viability of encapsulated rat pancreatic islets during transplantation. J Vasc Res (2003) 0.89
Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol (2002) 0.87
Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells. Growth Factors (1994) 0.84
Beta-cell sparing in transplanted islets by vascular endothelial growth factor. Transplant Proc (2004) 0.84
The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies. Transplantation (1993) 0.83
Portal vein immunosuppressant levels and islet graft toxicity. Transplant Proc (1998) 0.82
Immunohistochemical studies on vascular endothelial growth factor and platelet endothelial cell adhesion molecule-1/CD-31 in islet transplantation. Pancreas (2000) 0.76
Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science (1947) 9.51
Protective effect of breast feeding against infection. BMJ (1990) 5.88
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J Bone Joint Surg Br (2000) 4.30
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Accidental dural puncture and post dural puncture headache in obstetric anaesthesia: presentation and management: a 23-year survey in a district general hospital. Anaesthesia (2008) 3.48
Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity (1995) 3.18
Bird attack on milk bottles: possible mode of transmission of Campylobacter jejuni to man. Lancet (1990) 2.97
Disease mapping models: an empirical evaluation. Disease Mapping Collaborative Group. Stat Med (2001) 2.88
Change in obstetric practice in response to fear of litigation in the British Isles. Lancet (1991) 2.78
Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br (2000) 2.78
Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65
Relation between early introduction of solid food to infants and their weight and illnesses during the first two years of life. BMJ (1993) 2.46
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
The respiratory burst oxidase. J Biol Chem (1994) 2.29
Quality of life measurements in patients with malignant disease: a review. J R Soc Med (1986) 2.28
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia (2005) 2.09
The ocular impression: A review of the literature and presentation of an alternate technique. J Prosthodont (2000) 2.08
'Ventilating in recovery'--the way forward: intensive therapy or postoperative critical care? Br J Anaesth (2002) 2.04
The use of various handwashing agents to decontaminate gloved hands. Br Dent J (1989) 2.03
Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol (2002) 1.95
The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy (2007) 1.91
Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol (2000) 1.90
The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia (2009) 1.87
The evidence for beta blockers in heart failure. BMJ (1999) 1.84
Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy (2011) 1.81
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer (2007) 1.75
Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol (2001) 1.74
The heart failure epidemic: exactly how big is it? Eur Heart J (2001) 1.73
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73
Analysis of pace-maker and repolarization currents in frog atrial muscle. J Physiol (1976) 1.72
VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis (2006) 1.71
Glomerular disease as a cause of isolated microscopic haematuria. Q J Med (1994) 1.70
In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol (1987) 1.70
Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus. J Am Chem Soc (1972) 1.69
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol (1995) 1.66
Radiation exposure to the hands of orthopaedic surgeons: are we underestimating the risk? Arch Orthop Trauma Surg (2005) 1.64
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta (2001) 1.63
Multivesicular exocytosis in rat pancreatic beta cells. Diabetologia (2011) 1.63
Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer (2004) 1.63
Oral androgens in the treatment of hypogonadal impotent men. J Urol (1994) 1.61
Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int (2006) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest (1994) 1.60
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol (2001) 1.57
Immune-mediated reactions to althesin (alphaxalone). Br J Anaesth (1976) 1.56
Identification of the pace-maker current in frog atrium. J Physiol (1976) 1.56
Bilateral anterior shoulder fracture-dislocation. A case report and a review of the literature. Int Orthop (1999) 1.53
A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia (2010) 1.53
Do facial averageness and symmetry signal health? Evol Hum Behav (2001) 1.52
Functional health status levels of primary care patients. JAMA (1983) 1.52
Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes (1983) 1.51
Direct effects of dexamethasone on human podocytes. Kidney Int (2006) 1.50
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill (2010) 1.46
Randomized clinical trial of fluid and salt restriction compared with a controlled liberal regimen in elective gastrointestinal surgery. Br J Surg (2013) 1.46
Friction burns within the tibia during reaming. Are they affected by the use of a tourniquet? J Bone Joint Surg Br (2002) 1.46
The effect of epidural blockade on gastric intramucosal pH in the peri-operative period. Anaesthesia (1996) 1.45
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest (1995) 1.44
Segmental tibial fractures: an assessment of procedures in 27 cases. Injury (2003) 1.44
Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene (2006) 1.44
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant (1993) 1.43
Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis (1993) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes (1992) 1.40
An enhancing optic nerve lesion: malignant glioma of adulthood. Can J Ophthalmol (1997) 1.39
Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J (Clin Res Ed) (1987) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Nebulized bacteriostatic saline as a cause of bronchitis. J Fam Pract (1995) 1.38
Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 1.38
Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia (2005) 1.38
Attractiveness of facial averageness and symmetry in non-western cultures: in search of biologically based standards of beauty. Perception (2001) 1.37
Measurement of volatile fatty acid production rates in the cecum of the pony. J Anim Sci (1976) 1.37
The natural occurrence of insulin receptors in groups on adipocyte plasma membranes as demonstrated with monomeric ferritin-insulin. J Supramol Struct (1977) 1.37
Nature of the genetic determinant controlling encapsulation in Staphylococcus aureus Smith. Infect Immun (1977) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis (1978) 1.33
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest (1996) 1.33
Molecular characterization of the alpha-glucosidase gene (malA) from the hyperthermophilic archaeon Sulfolobus solfataricus. J Bacteriol (1998) 1.33
Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg Br (1999) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Ultrastructural localization of insulin receptors on adipocytes. Proc Natl Acad Sci U S A (1975) 1.32
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Injury patterns associated with mortality following motorcycle crashes. Injury (2002) 1.29
Spectrum of spontaneous frameshift mutations. Sequences of bacteriophage T4 rII gene frameshifts. J Mol Biol (1986) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci (1999) 1.27
Electron microscopic demonstration of insulin receptors on adipocyte plasma membranes utilizing a ferritin-insulin conjugate. J Biol Chem (1974) 1.26
Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs (2000) 1.26